相关实验视频

Updated: Sep 17, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

新辅助化学放射治疗的免疫场景:涉及MAL,T细胞分化蛋白质

Kosei Nakajima^1,2,3, Yoshinori Ino¹

¹Division of Molecular Pathology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, 104-0045, Tokyo Japan.

Oncology research

|July 4, 2025

概括

新辅助疗法 (NAT) 通过激活树突细胞和增加CD8+T细胞来增强抗瘤免疫力. 这项研究显示,NAT增强了胰腺癌患者的免疫反应,特别是通过DC-SIGN和MAL途径.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物信息学是一种生物信息学.

背景情况:

新辅助/手术前治疗 (NAT) 对局部晚期瘤至关重要,旨在减少瘤大小并改善手术结果.
虽然已知NAT可诱导局部抗瘤免疫,但其精确的分子机制尚未完全理解.
了解这些机制对于优化癌症治疗策略至关重要.

研究的目的:

阐明新辅助疗法 (NAT) 调节胰腺癌免疫微环境的分子机制.
识别受NAT影响的特定免疫路径和细胞群.
为进一步研究NAT在固体瘤中的免疫调节作用提供基础.

主要方法:

对接受NAT (n=26) 和未接受NAT (n=20) 的胰腺癌患者队列样本的分析.
分层生物信息学方法包括免疫相关基因的热图分析,基因本体学,基因组丰富分析 (GSEA) 和发明路径分析 (IPA).
通过免疫组织化学分析验证发现.

主要成果:

NAT上调了212个基因,包括DC-SIGN (CD209),并激活了13个免疫路径,如T细胞受体 (TCR) 信号传递.
通过对MAL (T细胞分化蛋白) 的上调,NAT促进了向CD8+T细胞种群的转变.
免疫组织化学证实,NAT治疗患者的DC-SIGN+树突细胞和MAL+淋巴细胞增加.

结论:

NAT通过通过DC-SIGN+树突细胞和MAL+淋巴细胞促进CD8+T细胞生成来增强抗瘤免疫力.
这项研究是首次报告NAT之后MAL+淋巴细胞的增加.
进一步研究NAT在其他固体瘤中的免疫调节作用是有必要的.

关键词:

抗瘤免疫力抗瘤免疫力新辅助/手术前治疗 (NAT)在T细胞分化过程中.

更多相关视频

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...